Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 19, 2013Cardiovascular ResearchOpen Access

Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology

View Full Paper
Ask AI
Bookmark
Share

Population

Patients with coronary heart disease (CHD) and acute myocardial ischaemia-reperfusion injury (IRI)

Design

Guideline

Authors

DHDerek J. HausenloyHBHans Erik BøtkerGCGianluigi Condorelli

Discussion

Loading...

Member takes

Overview

Adoption of these design recommendations should accelerate translation of cardioprotective therapies; extends prior consensus on ischemia-reperfusion trial standards.

Structured PICO

P
Population
Patients with coronary heart disease (CHD) and acute myocardial ischaemia-reperfusion injury (IRI)
I
Intervention
Cardioprotective therapies

This ESC position paper outlines recommendations for optimizing clinical trial design to successfully translate cardioprotective therapies for ischemia-reperfusion injury into clinical practice.

Cite This Study

Hausenloy et al. (2013) studied this question.

synapsesocial.com/papers/6a7665213da069e66cbd2ceehttps://doi.org/10.1093/cvr/cvt004
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Infarct Size Reduction in Patients With STEMI: Why We Can Do It!2011 · 9 citations
  2. 2Effect of Iron Chelation on Myocardial Infarct Size and Oxidative Stress in ST-Elevation–Myocardial Infarction2012 · 99 citations
  3. 3Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy. A double-blind, placebo-controlled, randomized trial2000 · 75 citations
  4. 4Cardiac effects of postconditioning depend critically on the duration of index ischemia2006 · 110 citations